Get the Stockscreener App
6.89
1.32%
0.09
After Hours:
6.89
Profound Medical Corp stock is traded at $6.89, with a volume of 28,695.
It is up +1.32% in the last 24 hours and down -17.58% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
See More
Previous Close:
$6.80
Open:
$6.8
24h Volume:
28,695
Relative Volume:
0.31
Market Cap:
$251.71M
Revenue:
$18.81M
Net Income/Loss:
$-38.90M
P/E Ratio:
-5.5226
EPS:
-1.2476
Net Cash Flow:
$-38.83M
1W Performance:
+0.58%
1M Performance:
-17.58%
6M Performance:
-7.89%
1Y Performance:
+55.88%
1-Day Range:
$6.7501
$6.96
1-Week Range:
$6.72
$7.06
52-Week Range:
$3.76
$8.95
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
6.89 | 242.94M | 18.81M | -38.90M | -38.83M | -1.2476 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
Profound Medical Stock And 2 Canadian AI Healthcare Stocks To Watch - Yahoo Finance
Profound Medical to Present at BIG10 Growth Conference - TipRanks
Profound Medical (NASDAQ: PROF) plans one-on-one investor talks at BIG10 conference - Stock Titan
Profound Medical Corp. (PROF) Peer Comparison – Compare with Others - Value Research
Profound Medical to Participate in Lake Street's 10th Annual Best Ideas Growth Conference - investingnews.com
Profound Medical Corp. to Present at Lake Street Capital Markets BIG10 Conference on September 10 - kalkine.ca
Profound Medical Names Richard Fabian as New President - TipRanks
Profound Medical names Richard R. Fabian as President; Mathieu Burtnyk becomes CTO - TradingView
New Profound Medical (PROF) president set for $550,000 salary plus stock awards - Stock Titan
(PROF) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Profound Medical names Richard Fabian as president By Investing.com - Investing.com Australia
Profound Medical Appoints Richard Fabian as President - marketscreener.com
Profound Medical Taps Industry Veteran Richard Fabian as President in Leadership Realignment - tipranks.com
Profound Medical Names Industry Veteran Richard Fabian as President in Leadership Realignment - TipRanks
Profound Medical Appoints Richard Fabian President - marketscreener.com
Profound Medical Corp. Announces Executive Changes - marketscreener.com
Profound Medical Corp. (PROF) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Profound Medical Corp. (PROF) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Profound Medical Stock Falls 2.63%: Can TSX:PRN Overcome Commercialization Challenges and Healthcare Technology Risks? - kalkine.ca
Profound Medical Corp. (TSX:PRN) Gains Momentum as TULSA-PRO Innovation Strengthens Healthcare Technology Outlook - kalkine.ca
Could AI Reshape Canada’s Healthcare Stocks? (TSX:PRN) - Kalkine Media
Profound Medical Corp. Stock Surges 4.46% as Trading Activity Spikes and Market Attention Builds - kalkine.ca
Why Did Profound Medical Corp. (TSX:PRN) Stock Suffer a 6.67% Drop on 20 August 2026? - kalkine.ca
Profound Medical Slides Despite New MRI Technology and a Narrower Loss — Why Aren't Investors Convinced? - kalkine.ca
Profound (PROF) Earnings Report: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Investor Response: The Stock Ends Down 6.07% in the Available RecordRevenue Warning Signal - vinanet.vn
Profound Medical (PROF) Q2 2026 Earnings Call Transcript - AOL.ca
Why Did Profound Medical Corp. (TSX:PRN) Surge 6.09% on 18 August 2026? - kalkine.ca
Why Profound Medical Corp stock surged yesterday - Wealth Awesome
Profound Medical Stock: Record Orders Meet a CFO Shake-Up - kalkine.ca
Profound Medical (TSX:PRN) Captures Focus Amid Developing Healthcare Story - Kalkine Media
Why Profound Medical Corp stock is skyrocketing today - Wealth Awesome
Profound Medical (TSX:PRN): Could The Market Be Seeing More Potential Ahead? - Kalkine Media
Profound Medical Names Matthew Sobczyk as Interim CFO Following Rashed Dewan’s Departure - Kalkine Media
Profound Medical (TSE:PRN) Insider Thomas Michael Tamberrino Buys 3,755 Shares of Stock - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Profound Medical Launches TULSA-PRO Software Upgrade Targeting Up to Six Procedures Per Day - Minichart
Profound Medical Launches Enhanced TULSA-PRO Software Upgrade - TipRanks
Form 8K PROFOUND MEDICAL CORP. For: 17 August By Investing.com - Investing.com Nigeria
Profound Medical Names Interim CFO Amid Leadership Transition - TipRanks
Profound Medical (NASDAQ: PROF) targets higher TULSA throughput - Stock Titan
Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’ - marketscreener.com
Some physicians report four TULSA procedures a day—what changes next? - Stock Titan
Profound Medical (PROF) shifts CFO, ex-finance chief stays on as paid adviser - Stock Titan
Profound Medical Announces Management Change - The Manila Times
Profound Medical Corp. Announces CFO Changes - marketscreener.com
Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times
Profound Medical Unveils 'Let's Huddle' Patient Advocacy Program in August 2026 Filing - Kalkine Media
Profound Medical Launches Global Prostate Patient Advocacy Community - TipRanks
Profound Medical (PROF) launches global ‘Let’s Huddle’ prostate patient community - Stock Titan
A prostate cancer survivor helps men navigate care through Let's Huddle - Stock Titan
Profound Medical Launches ‘Let's Huddle’, a Global - globenewswire.com
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.86%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):